Skip to main content

Drug Interactions between Cotolone and Tapazole

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

prednisoLONE methIMAzole

Applies to: Cotolone (prednisolone) and Tapazole (methimazole)

MONITOR: The clearance of prednisolone may be increased when coadministered with some antithyroid agents, such as carbimazole and methimazole. The mechanism for this interaction has not been delineated, but may involve induction of CYP450-mediated metabolism of prednisolone. In one study, 6 hours after a 540 mcg/kg IV dose of prednisolone, the prednisolone plasma levels in patients receiving methimazole or carbimazole were approximately 10% of those in healthy subjects and were undetectable after 8 hours. In the healthy subjects, who had not taken methimazole or carbimazole, total and unbound prednisolone levels were higher and measurable over the entire 10-hour study period. It is unknown if other corticosteroids are affected similarly.

MANAGEMENT: Patients should be closely monitored for altered efficacy and safety while achieving a euthyroid state or when carbimazole or methimazole are added, discontinued, or the dosage is changed. Prednisolone dosage adjustments may be required. Patients should be advised to notify their clinician if they experience a worsening or change in their symptoms.

References

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
  2. Cerner Multum, Inc. "Australian Product Information."
  3. Legler UF (1988) "Impairment of prednisolone disposition in patients with Graves' disease taking methimazole." J Clin Endocrinol Metab, 66, p. 221-3

Switch to consumer interaction data

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.